Clinical trial
Carotid Atherosclerosis in Predicting Coronary Artery Disease
NCT06253962 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Carotid Atherosclerosis in Predicting Coronary Artery Disease
- Lead sponsor
- Shanghai Zhongshan Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 10, 2024
- Completion date
- December 31, 2028
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
carotid atherosclerosis, coronary atheroscleroses